Prior notification of a concentration (Case M.9583 — TPG/Hong Leong Group/Columbia Asia Healthcare) Candidate case for simplified procedure (Text with EEA relevance) 2019/C 400/14
Date: 2019-11-26
Institutions: Directorate-General for Competition, European Commission
Subjects: banking, economic concentration, financial services, health care, holding company, investment company, medical centre, medical institution, merger control, real estate business








C_2019400EN.01002001.xml










26.11.2019   


EN


Official Journal of the European Union


C 400/20






Prior notification of a concentration
(Case M.9583 — TPG/Hong Leong Group/Columbia Asia Healthcare)
Candidate case for simplified procedure
(Text with EEA relevance)
(2019/C 400/14)

1.   
On 18 November 2019, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


TPG Asia VI SF Pte. Ltd. (‘TPG Asia’, Singapore), belonging to TPG Group, USA,










—


Hong Leong Healthcare Group Sdn Bhd (‘Hong Leong’, Malaysia), belonging to Hong Leong Group, Malaysia,










—


Columbia Asia Healthcare Pte. Ltd. (‘CAHSG’, Singapore).




TPG Asia and Hong Leong acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of CAHSG.
The concentration is accomplished by way of purchase of shares.


2.   
The business activities of the undertakings concerned are:






—


for TPG Asia: part of TPG Group, a private investment firm that manages a family of funds that invest in a variety of companies through acquisitions and corporate restructurings. TPG Asia forms part of the TPG Capital Asia platform, which focuses on Asian investments,










—


for Hong Leong: part of Hong Leong Group, a conglomerate with diversified businesses in banking and financial services, manufacturing and distribution, property development and investments, hospitality, and leisure. Hong Leong was established on August 20, 2019 for the purpose of acquiring CAHSG and will focus on the healthcare sector,










—


for CAHSG: the holding entity for the Columbia Asia Group, a private healthcare company founded in 1996 to provide accessible, affordable, and high-quality healthcare to meet the needs of the Asian population. CAHSG has 18 facilities across Asia: 12 hospitals in Malaysia, 2 hospitals and 1 clinic in Vietnam, and 3 hospitals in Indonesia. It currently also operates 11 hospitals in India, which will be carved out from the transaction perimeter.






3.   
On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.
Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.


4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.9583 — TPG/Hong Leong Group/Columbia Asia Healthcare
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:
Email: COMP-MERGER-REGISTRY@ec.europa.eu
Fax +32 22964301
Postal address:





European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2)  OJ C 366, 14.12.2013, p. 5.